ACTIVATED PARTIAL THROMBOPLASTIN TIME REAGENTS - AN EVALUATION

被引:0
作者
HOWARTH, S
机构
关键词
ACTIVATED PARTIAL THROMBOPLASTIN TIME; AUTOMATION; COAGULATION;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Nine automated, activated partial thromboplastin time (APTT) reagents were evaluated on an automated coagulometer, in comparison with a manual reagent. The study consisted of three separate stages: 1) to choose a reagent that had a working stability between 4-degrees-C and 8-degrees-C for seven days and heparin sensitivity between 0 and 0.8 iu/ml; ii) assessment of sensitivity to specific factor deficiencies, particularly factors VIII, IX, XI and XII using standardised plasma serially diluted with factor-deficient plasma; and iii) assessment of sensitivity to the presence of a lupus anticoagulant, from a known positive panel. Only one reagent fulfilled all the essential criteria as an acceptable replacement for the manual reagent.
引用
收藏
页码:109 / 113
页数:5
相关论文
共 50 条
  • [41] Automated heparin-delivery system to control activated partial thromboplastin time - Evaluation in normal volunteers
    Cannon, CP
    Dingemanse, J
    Kleinbloesem, CH
    Jannett, T
    Curry, KM
    Valcke, CP
    CIRCULATION, 1999, 99 (06) : 751 - 756
  • [42] Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents
    Dale, B. J.
    Ginsberg, J. S.
    Johnston, M.
    Hirsh, J.
    Weitz, J. I.
    Eikelboom, J. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (11) : 1810 - 1815
  • [43] Activated clotting time or activated partial thromboplastin time as the method of choice for patients undergoing neuroradiological intervention
    R. Kubalek
    A. Berlis
    M. Schwab
    J. Klisch
    M. Schumacher
    Neuroradiology, 2003, 45 : 325 - 327
  • [44] MEDICAL CONDITIONS ASSOCIATED WITH PROLONGED ACTIVATED PARTIAL THROMBOPLASTIN TIME IN SWAT
    Shah, Mukamil
    Khattak, Imran ud Din
    Khattak, Sania Tanweer
    Ahad, Abdul
    Mahsud, Muhammad Amin Jan
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2011, 9 (01): : 15 - 18
  • [45] Recommendations for Appropriate Activated Partial Thromboplastin Time Reagent Selection and Utilization
    Fritsma, George A.
    Dembitzer, Francine R.
    Randhawa, Ankush
    Marques, Marisa B.
    Van Cott, Elizabeth M.
    Adcock-Funk, Dorothy
    Peerschke, Ellinor I.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (06) : 904 - 908
  • [46] Plasma Antiphospholipid Antibodies Effects on Activated Partial Thromboplastin Time Assays
    Yao, Ke
    Zhang, Lingyun
    Zhou, Hang
    Tang, Ning
    Li, Dengju
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2017, 354 (01) : 22 - 26
  • [47] EFFECT OF SYNTHETIC PHOSPHOLIPIDS ON THE RESPONSE OF THE ACTIVATED PARTIAL THROMBOPLASTIN TIME TO HEPARIN
    VANDENBESSELAAR, AMHP
    NEUTEBOOM, J
    BERTINA, RM
    BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (06) : 895 - 903
  • [48] BEDSIDE MONITORING OF HEPARIN-THERAPY - COMPARISON OF ACTIVATED CLOTTING TIME TO ACTIVATED PARTIAL THROMBOPLASTIN TIME
    REINER, JS
    COYNE, KS
    LUNDERGAN, CF
    ROSS, AM
    CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1994, 32 (01): : 49 - 52
  • [49] Activated clotting time or activated partial thromboplastin time as the method of choice for patients neuroradiological undergoing intervention
    Kubalek, R
    Berlis, A
    Schwab, M
    Klisch, J
    Schumacher, M
    NEURORADIOLOGY, 2003, 45 (05) : 325 - 327
  • [50] Influence of vitamin K antagonist treatment on activated partial thromboplastin time
    Mulliez, Sylvie M. N.
    Van den Bogaert, Julie
    Devreese, Katrien M. J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (02) : E47 - E50